BRPI0513118A - vìrus recombinante do mal de marek, vacina e uso de um vìrus - Google Patents

vìrus recombinante do mal de marek, vacina e uso de um vìrus

Info

Publication number
BRPI0513118A
BRPI0513118A BRPI0513118-9A BRPI0513118A BRPI0513118A BR PI0513118 A BRPI0513118 A BR PI0513118A BR PI0513118 A BRPI0513118 A BR PI0513118A BR PI0513118 A BRPI0513118 A BR PI0513118A
Authority
BR
Brazil
Prior art keywords
virus
vaccine
recombinant marek
marek
recombinant
Prior art date
Application number
BRPI0513118-9A
Other languages
English (en)
Inventor
Martin Allday
Venogopal Nair
Andrew Brown
Original Assignee
Imp Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imp Innovations Ltd filed Critical Imp Innovations Ltd
Publication of BRPI0513118A publication Critical patent/BRPI0513118A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

VìRUS RECOMBINANTE DO MAL DE MAREK, VACINA E USO DE UM VìRUS A presente invenção refere-se ao vírus do mal de Marek que tem uma mutação em um ou ambos os seus genes Meq de uma maneira tal que o vírus seja não patogênico. A presente invenção também se refere a uma vacina que compreende tal vírus, e ao uso do vírus em medicina.
BRPI0513118-9A 2004-07-09 2005-07-08 vìrus recombinante do mal de marek, vacina e uso de um vìrus BRPI0513118A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0415437.3A GB0415437D0 (en) 2004-07-09 2004-07-09 Recombinant virus
PCT/GB2005/002712 WO2006005934A1 (en) 2004-07-09 2005-07-08 Recombinant marek’s disease virus

Publications (1)

Publication Number Publication Date
BRPI0513118A true BRPI0513118A (pt) 2008-04-29

Family

ID=32865742

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513118-9A BRPI0513118A (pt) 2004-07-09 2005-07-08 vìrus recombinante do mal de marek, vacina e uso de um vìrus

Country Status (4)

Country Link
US (1) US20080095797A1 (pt)
BR (1) BRPI0513118A (pt)
GB (1) GB0415437D0 (pt)
WO (1) WO2006005934A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010008528A2 (en) * 2008-07-18 2010-01-21 The Texas A&M University System Marek's disease virus vaccine compositions and methods of using thereof
CN102628053B (zh) * 2010-12-14 2013-10-09 山东农业大学 重组鸡马立克氏病病毒sc9-1株和sc9-2株的构建和应用
CN102344914B (zh) * 2011-09-07 2013-02-13 肇庆大华农生物药品有限公司 一种表达REV env的重组MDV毒株的构建和应用
FR3001975A1 (fr) * 2013-02-14 2014-08-15 Denis Rasschaert Mutants d'herpesvirus aviaire obtenus par deletion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214524B1 (en) * 2003-05-06 2007-05-08 The United States Of America, As Reprsented By The Secretary Of Agriculture Marek's disease virus vaccine

Also Published As

Publication number Publication date
US20080095797A1 (en) 2008-04-24
WO2006005934A1 (en) 2006-01-19
GB0415437D0 (en) 2004-08-11

Similar Documents

Publication Publication Date Title
BR0014386A (pt) Composição
O’Driscoll Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment
BR0113822A (pt) Vacina
NO20061912L (no) Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system
BR0111732A (pt) Prodrogas de 2-deóxi-beta-l-nucleosìdeos
MA33449B1 (fr) Antigènes recombinants du vrs
AR052625A1 (es) Nueva composicion
PT1187629E (pt) Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
BRPI0208183B8 (pt) peptídeo antígeno de câncer modificado por wt1 e vacinas para câncer
ATE295180T1 (de) Zubereitung zur immunisierung gegen den aids- virus
BR0309339A (pt) Vìrus vaccinia modificado ankara para a vacinação de neonatos
ATE452900T1 (de) Impfstoff gegen das west-nile-virus
BR0312474A (pt) Partìcula viral adjuvante
BR112015017966A2 (pt) composições imunogênicas compreendendo vírus silificado e métodos de uso
BR112012021650A2 (pt) "parvovírus recombinante atenuado, vacina para a proteção de animais contra infecção com parvovírus, método para a obtenção de um parvovírus recombinante, e, uso de uma vacina."
BRPI0513118A (pt) vìrus recombinante do mal de marek, vacina e uso de um vìrus
Van Braeckel‐Budimir et al. Influenza‐induced lung Trm: not all memories last forever
BR0308860A (pt) Fator viii modificado
MY144492A (en) Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types
BRPI0516542A (pt) composição de vacina eficaz na prevenção ou melhora de infecção pelo vìrus da influenza aviária; método para prevenir ou melhorar a eclosão de infecção pelo vìrus da influenza aviária
EP2368985A3 (en) Compositions and methods for generating an immune response
AR054259A1 (es) Vacuna contra virus de papiloma humano (hpv)
AR124384A1 (es) Parapoxvirus modificado que tiene inmunogenicidad aumentada
CA2295316A1 (en) Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy
MA32003B1 (fr) Vaccin

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.